Page last updated: 2024-12-09
3-amino-5-mercapto-1,2,4-triazole
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
3-amino-5-mercapto-1,2,4-triazole: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 2723869 |
| CHEMBL ID | 3187666 |
| SCHEMBL ID | 94802 |
| SCHEMBL ID | 11413174 |
| MeSH ID | M0470025 |
Synonyms (84)
| Synonym |
|---|
| AC-16289 |
| AKOS002350449 |
| 5-amino-4h-[1,2,4]triazole-3-thiol |
| nsc34807 |
| nsc-34807 |
| 5-amino-1,2-dihydro-3h-1,2,4-triazole-3-thione |
| 1,4-triazolidine-3-thione, 5-imino- |
| iminothiourazole |
| 3-amino-5-mercapto-1,4-triazole |
| nsc-145149 |
| 3h-1,4-triazole-3-thione, 5-amino-1,2-dihydro- |
| 16691-43-3 |
| nsc145149 |
| ent 61388 |
| s-triazole-3-thiol, 5-amino- |
| 3-imino-5-thiourazole |
| 3-amino-1,2,4-triazole-5-thiol, 95% |
| 5-amino-1,2-dihydro-3h,1,2,4-triazole-3-thione |
| nsc 145149 |
| 3-amino-1,2,4-triazole-5-thiol |
| 3h-1,2,4-triazole-3-thione, 1,2-dihydro-5-amino- |
| 1,2,4-triazolidine-3-thione, 5-imino- |
| 3h-1,2,4-triazole-3-thione, 5-amino-1,2-dihydro- |
| 3-amino-5-mercapto-1,2,4-triazole |
| 1,2-triazolidine-3-thione, 5-imino- |
| 1,2-dihydro-5-amino-3h-1,2,4-triazole-3-thione |
| ai3-61388 |
| einecs 240-735-6 |
| 3-amino-4h-1,2,4-triazole-5-thiol |
| AKOS000276288 |
| AKOS000813709 |
| STK803268 |
| 3-amino-1h-1,2,4-triazole-5-thiol |
| AKOS001051876 |
| 5-amino-1,2-dihydro-1,2,4-triazole-3-thione |
| AKOS000119697 |
| 5-azanyl-1,2-dihydro-1,2,4-triazole-3-thione |
| A810790 |
| unii-353f2d8l1z |
| 353f2d8l1z , |
| dtxcid5024849 |
| dtxsid7044849 , |
| cas-16691-43-3 |
| NCGC00256233-01 |
| tox21_301609 |
| BBL004942 |
| 5-amino-4h-1,2,4-triazole-3-thiol |
| F3250-0579 |
| BP-10581 |
| FT-0615006 |
| 5-amino-1h-1,2,4-triazole-3-thiol |
| F9995-0407 |
| SCHEMBL94802 |
| 5-amino-3-mercapto-4h-[1,2,4]triazole |
| 3-amino-5-mercapto-1h-1,2,4-triazole |
| 5-amino-3-mercapto-1,2,4-triazole |
| 3-amino-5-mercapto-s-triazole |
| 5-amino-3-mercapto-1,2,4--triazole |
| SCHEMBL11413174 |
| W-107914 |
| BS-3747 |
| 5-amino-4h-1,2,4-triazol-3-yl hydrosulfide # |
| 3-mercapto-5-amino-1,2,4-triazole |
| 5-amino-1h-(1,2,4)triazole-3-thiol |
| 2-amino-5-mercapto-1,3,4-triazole |
| 3-thio-5-amino-1,2,4-triazole |
| 4h-3-amino-5-mercapto-1,2,4-triazole |
| 5-mercapto-3-amino-1,2,4-triazole |
| CHEMBL3187666 |
| mfcd00005231 |
| VU0607279-1 |
| CS-B1269 |
| 5-amino-3,4-dihydro-2h-1,2,4-triazole-3-thione |
| 5-imino-1,2,4-triazolidine-3-thione |
| 5-amino-1,2-dihydro-3h-1,2,4-tri-azole-3-thione |
| Q26841259 |
| 3-amino-5-mercapto-[1,2,4]triazole |
| AMY25588 |
| mfcd00755416 |
| amino-1,2,4-triazole-3-thiol |
| EN300-260497 |
| 5-amino-2,3-dihydro-1h-1,2,4-triazole-3-thione |
| Z56913172 |
| PD148022 |
Research Excerpts
Toxicity
| Excerpt | Reference | Relevance |
|---|---|---|
| "We concluded that long-term exposure of astrocytes to ethanol is more toxic than acute exposure." | ( Comparison of ethanol and acetaldehyde toxicity in rat astrocytes in primary culture. Lipnik-Stangelj, M; Sarc, L, 2009) | 0.35 |
Dosage Studied
| Excerpt | Relevance | Reference |
|---|---|---|
| " The protein content study showed biphasic dose-response curves, after 24 hours and seven days of exposure to either ethanol or acetaldehyde." | ( Comparison of ethanol and acetaldehyde toxicity in rat astrocytes in primary culture. Lipnik-Stangelj, M; Sarc, L, 2009) | 0.35 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Protein Targets (1)
Potency Measurements
| Protein | Taxonomy | Measurement | Average (µ) | Min (ref.) | Avg (ref.) | Max (ref.) | Bioassay(s) |
|---|---|---|---|---|---|---|---|
| acetylcholinesterase | Homo sapiens (human) | Potency | 89.3584 | 0.0025 | 41.7960 | 15,848.9004 | AID1347398 |
| [prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] | |||||||
Research
Studies (15)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (46.67) | 29.6817 |
| 2010's | 7 (46.67) | 24.3611 |
| 2020's | 1 (6.67) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 33.90
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (33.90) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 16 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||